You are here : ERS > E-Resources > Tools > Search > Sunday 05.09.2004 > New and emerging pharmacological strategies in the treatment of asthma > Bronchial asthma as neurogenic paroxysmal disease - high effectiveness of carbamazepine in asthma monotherapy

Search

New and emerging pharmacological strategies in the treatment of asthma
1396
Bronchial asthma as neurogenic paroxysmal disease - high effectiveness of carbamazepine in asthma monotherapy
Place a comment or grade

M. Lomia, Z. Chapichadze, M. Pruidze (Tbilisi, Georgia)
Abstract

Abstract
Purpose. Based on the assumption that bronchial asthma has certain neurogenic paroxysmal mechanism and links with other paroxysmal diseases - breath-holding attacks, epilepsy and migraine, we decided to search antiasthmatic activity of carbamazepine, and the frequency of EEG and neurological signs during asthma. We also investigated correlates of these signs with asthma signs.
Methods. The efficacy of carbamazepine in these patients in randomized, double-blind, placebo-controll... [View all]

WHAT YOU CAN FIND HERE  
Full text article ERJ full text articles
PDF file PDF journal article, handouts & slides
Abstract Congress or journal article abstract
Powerpoint slides Slide presentations
e-posters  e-poster
Webcast Webcasts
Multimedia file Multimedia files for portable devices 
Interactive material Interactive material

                 
ERS